The Healthcare Information and Management Systems Society is relatively upbeat in its assessments of the rules that HHS released last week governing the federally funded electronic health-records incentive payment programs.
Read the full story: http://tinyurl.com/8qopj8r
Source: ModernHealthcare.com
On Thursday, the CMS released its 672-page final rule (PDF) setting the Stage 2 meaningful-use criteria that hospitals, office-based physicians and other eligible professionals must meet to qualify for federal EHR incentive payments. HHS' Office of the National Coordinator for Health Information Technology also released its 474-page companion final rule (PDF), which guides EHR developers on what they must do to build, test and certify systems that qualify for use in the program that will pay about $27 billion in incentive payments to providers to adopt and meaningfully use health information technology.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Researchers Identify Potential Biomarkers for SMA Motor Improvement Following Nusinersen Treatment
November 17th 2023A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Read More